查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1999468

吸入式一氧化氮输送系统市场：依技术、输送装置、输送方式、应用、最终用户和通路划分－2026-2032年全球市场预测

Inhaled Nitric Oxide Delivery Systems Market by Technology, Delivery Device Type, Mode Of Delivery, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，吸入式一氧化氮输送系统市场价值将达到 3.414 亿美元，到 2026 年将成长至 3.7933 亿美元，到 2032 年将达到 6.9118 亿美元，复合年增长率为 10.60%。

主要市场统计数据
基准年 2025 3.414亿美元
预计年份：2026年 3.7933亿美元
预测年份 2032 6.9118亿美元
复合年增长率 (%) 10.60%

全面介绍吸入式一氧化氮输送系统，概述其在现代医疗保健环境中的临床效用、技术进步和采购重点。

吸入式一氧化氮输送系统在急性呼吸护理、心胸支持和新生儿重症监护中发挥着至关重要的作用，当传统治疗方法不佳时，它能提供靶向肺血管扩张。这些系统已从集中管理的钢瓶发展到配备整合监测功能的先进电子发生器，从而实现了更精准的给药、更高的安全性以及更广泛的应用，包括门诊和居家医疗环境。临床医生、医院管理者和医疗设备製造商正在积极应对由临床证据、技术创新和不断发展的医疗保健服务模式所塑造的局面，这些模式优先考虑便携性、安全性和易用性。

临床创新、医疗保健的去中心化以及对证据的期望正在迅速改变吸入式一氧化氮解决方案的竞争格局和营运环境。

吸入式一氧化氮治疗领域正经历一场变革，其驱动力源自于临床需求、技术进步以及医疗服务模式的转变。电子发生器设计的进步改变了人们对便携性、自动化监测以及与电子健康记录整合等方面的预期，从而拓展了其在加护病房以外的应用范围。同时，给药精准度和警报系统的改进提高了安全标准，促使临床团队重新评估传统的禁忌症，并探索针对特定呼吸系统和心臟疾病的早期介入策略。

本研究评估了美国关税措施可能对 2025 年医疗设备的采购、分销和采购惯例的多方面营运和供应链影响。

关税等政策措施会对整个吸入式一氧化氮生态系统产生连锁反应，改变零件的成本结构、进口趋势和供应商的议价能力，而未必会改变其临床应用原理。当关税增加进口发生器、气瓶或电子元件的接收成本时，製造商通常会重新考虑其筹资策略，例如将部分生产转移回国内、实现供应商多元化或重新设计产品以减少对受关税管制零件的依赖。这些供应侧的调整会对采购计画和合约谈判产生后续影响，因为买家可能会要求更长的前置作业时间和更明确的供应保证。

详细的細項分析揭示了应用、最终用户、技术、设备类型、分销管道和管理方法如何塑造差异化的临床和商业策略。

细分市场分析清楚地突显了每种应用、最终用户、技术、给药设备类型、分销管道和给药方法的临床、营运和商业性需求。基于应用，市场研究涵盖了广泛的患者群体，从成人患者（不同的临床路径需要不同的给药策略和监测强度，例如心臟手术中的低氧血症和肺动脉高压）到新生儿患者（需要高度灵敏的控制和严格的安全功能，例如缺氧性呼吸衰竭和持续性新生儿肺动脉高压）。儿童患者介于两者之间，通常需要能够适应其体型和给药复杂性的设备。按最终用户划分，涵盖了优先考虑处理能力和易于设置的门诊中心和诊所、强调便携性和看护者培训的医疗保健项目，以及将与重症监护系统的整合和互通性视为重中之重的医院。

美洲、欧洲、中东和非洲以及亚太地区各区域市场的市场动态和临床部署模式，影响着进入、采购和商业化。

区域趋势对临床部署模式、报销方式以及製造商和经销商的策略重点有显着影响。在美洲，实力雄厚的大学医院以及心胸外科和新生儿专科项目集群是早期临床部署和真实世界数据（REW）生成的中心，采购週期通常体现了与大规模医疗系统进行全面评估和谈判的过程。因此，人们越来越关注设备互通性、服务支援模式以及能够支援长期临床研究的合约条款。

主要製造商和服务供应商如何透过安全性、证据生成和高度适应性的商业模式实现差异化并确保临床应用。

吸入式一氧化氮输送领域的主要企业正在多个方面进行投资，包括专注于安全性和易用性的工程设计、建造能够证明临床差异化的证据包，以及扩展服务组合以支持设备的长期运作。技术领导企业正专注于将监测、警报和与医院资讯系统的互通性集成，以减轻临床医生的负担并实现更安全的剂量调整通讯协定。专注于气瓶解决方案的竞争对手则透过优化供应物流和为尚未广泛采用电子产生器的医疗机构提供强大的支援网络来维持其市场地位。

产业领导者可以实施的可操作策略倡议，以加速采用、增强韧性，并在复杂的医疗保健系统中展现临床和经济价值。

产业领导者应优先考虑一系列切实可行的倡议，以巩固市场地位、提升临床影响力并降低营运风险。首先，投资于完善的上市后证据项目，不仅要衡量生理终点，还要衡量营运结果，例如住院时间、再入院率和看护者负担。这些数据将为报销谈判和医院采购决策提供支援。其次，建构灵活的经营模式，以满足客户偏好。这应包括资本租赁、管理服务和基于结果的合约等选项，以分散风险并促进长期伙伴关係。第三，增强设备互通性和数位化集成，以减轻医疗专业人员的工作量，并促进资料收集，从而推动品质改进倡议。

我们采用严谨的混合调查方法，结合临床访谈、医疗设备技术分析和监管审查，以确保平衡且可操作的见解。

本研究采用混合方法，结合定性专家访谈、医疗设备规格分析、监管文献回顾以及同行评审的临床证据，以全面了解吸入一氧化氮给药的现状。研究透过对新生儿、儿童和成人心肺专科的临床医生、急诊和门诊医疗机构的采购经理以及医疗设备製造商和分销商的高管进行结构化访谈，获得了关键见解。这些观点与医疗设备技术文件和监管申报文件进行了交叉比对，以评估其安全性、互通性和按司法管辖区分類的器械分类。

整合是将临床需求、技术趋势和组织策略连结起来的结论，可作为实施和长期规划的指南。

吸入式一氧化氮输送系统正处于临床需求、技术成熟度和不断演进的医疗服务模式交会的十字路口。这些设备的未来发展轨迹将持续受到以下需求的影响：提高安全性、增强便携性以及获得可证实的疗效，从而证明其不仅在传统医院环境中，而且在门诊和家庭环境中也具有更广泛的应用价值。那些能够开发出符合新生儿和成人重症监护环境实际情况的产品，同时投资于实证医学研究和供应链韧性的製造商和供应商，将最有利于实现可持续的临床应用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 吸入式一氧化氮输送系统市场：依技术划分

  • 瓦斯罐
  • 电子发生器
    • 固定的
    • 携带式的

第九章 吸入式一氧化氮输送系统市场（依输送装置类型划分）

  • 整合系统
  • 独立型

第十章 依给药方式分類的吸入式一氧化氮输送系统市场

  • 可持续的
  • 间歇性的

第十一章 吸入式一氧化氮输送系统市场：依应用划分

  • 成人版
    • 心血管手术中的低氧血症
    • 肺动脉高压
  • 新生
    • 低氧性呼吸衰竭
    • 新生儿持续性肺动脉高压
  • 儿童

第十二章 吸入式一氧化氮输送系统市场：依最终用户划分

  • 门诊部
  • 诊所
  • 家庭医疗保健
  • 医院

第十三章 吸入式一氧化氮输送系统市场：依通路划分

  • 直销
  • 销售代理
  • 线上管道

第十四章 吸入式一氧化氮输送系统市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 吸入式一氧化氮输送系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 吸入式一氧化氮输送系统市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国吸入式一氧化氮输送系统市场

第十八章：中国吸入式一氧化氮输送系统市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Air Liquide SA
  • Air Products and Chemicals, Inc.
  • Air Water Inc.
  • Bellerophon Therapeutics, Inc.
  • Beyond Air, Inc.
  • Chart Industries, Inc.
  • Dragerwerk AG & Co. KGaA
  • EKU Elektronik GmbH
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • INO Therapeutics LLC
  • International Biomedical Ltd.
  • Koninklijke Philips NV
  • Linde plc
  • Mallinckrodt Pharmaceuticals plc
  • Medtronic plc
  • Merck KGaA
  • Messer Group GmbH
  • NIOX Group plc
  • Novoteris, LLC
  • NU-MED Plus, Inc.
  • SLE Ltd.
  • Taiyo Nippon Sanso Corporation
  • Teleflex Incorporated
  • VERO Biotech LLC
Product Code: MRR-563BF1FCFB8B

The Inhaled Nitric Oxide Delivery Systems Market was valued at USD 341.40 million in 2025 and is projected to grow to USD 379.33 million in 2026, with a CAGR of 10.60%, reaching USD 691.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 341.40 million
Estimated Year [2026] USD 379.33 million
Forecast Year [2032] USD 691.18 million
CAGR (%) 10.60%

A comprehensive introduction to inhaled nitric oxide delivery systems that frames clinical utility, technological evolution, and procurement priorities for modern care settings

Inhaled nitric oxide delivery systems occupy a critical intersection between acute respiratory care, cardiothoracic support, and neonatal intensive care, offering targeted pulmonary vasodilation when conventional therapies are inadequate. These systems have evolved from centralized gas cylinders to advanced electronic generators with integrated monitoring, enabling more precise dosing, improved safety, and broader settings of use, including ambulatory care and home healthcare environments. Clinicians, hospital administrators, and device manufacturers are navigating a landscape shaped by clinical evidence, technological innovation, and evolving care delivery models that place a premium on portability, safety, and ease of use.

Transitioning from historical practice patterns, stakeholders are increasingly focused on optimizing patient outcomes while managing total cost of care. This requires a nuanced understanding of application-specific needs across adult, neonatal, and pediatric populations, as well as the comparative advantages of integrated systems versus standalone devices. As health systems emphasize continuity of care and shorter inpatient stays, delivery platforms that facilitate safe transition from hospital to home or outpatient settings are gaining strategic interest. Consequently, procurement decisions now balance clinical efficacy, operational workflow compatibility, and supply chain resilience, propelling a new wave of evaluation criteria among purchasers and clinical leaders.

How clinical innovation, decentralization of care, and evidence expectations are rapidly reshaping the competitive and operational landscape for inhaled nitric oxide solutions

The landscape for inhaled nitric oxide delivery is undergoing transformative shifts driven by convergence of clinical demand, technological innovation, and changes in care delivery models. Advances in electronic generator design have shifted expectations around portability, automated monitoring, and integration with electronic health records, thereby expanding potential use cases beyond the intensive care unit. Simultaneously, improvements in dosing precision and alarm systems have elevated safety benchmarks, prompting clinical teams to reassess traditional contraindications and explore earlier intervention strategies in select respiratory and cardiac contexts.

Concurrently, care decentralization is accelerating interest in devices suitable for ambulatory centers, home healthcare, and clinic-based programs. This movement is supported by growing emphasis on reducing hospital length of stay and readmission rates, which reorients decision-making toward devices that enable safe step-down care. Another notable shift is the maturation of integrated systems that combine delivery, monitoring, and supply management into single solutions, challenging the role of standalone devices and suppliers focused solely on gas cylinders. Finally, regulatory scrutiny and payer interest in demonstrating real-world clinical and economic value are prompting manufacturers to invest heavily in post-market evidence generation, outcomes research, and interoperability, creating a more evidence-driven commercialization environment.

Assessing the multifaceted operational and supply chain effects that United States tariff measures can exert on device sourcing, distribution, and procurement practices in 2025

Policy actions such as tariffs can reverberate across the inhaled nitric oxide ecosystem by altering component cost structures, import dynamics, and supplier bargaining power without necessarily changing the clinical rationale for use. When tariffs increase the landed cost of imported generators, cylinders, or electronic components, manufacturers often reassess sourcing strategies, which may include reshoring elements of production, diversifying supplier bases, or redesigning products to reduce dependence on tariff-exposed parts. These supply-side adaptations have downstream effects on procurement timelines and contract negotiations, as buyers seek longer lead times and clearer supply assurances.

Tariff-driven cost pressures also influence distribution strategies. Distributors and direct sales channels may recalibrate inventory policies and pricing models to preserve margins, which can temporarily constrain availability for certain hospital purchasing patterns. In parallel, higher input costs tend to accelerate adoption of technologies that reduce recurring expenditures, such as electronic generators that lower cylinder consumption or systems that enable intermittent dosing. From a regulatory and contracting perspective, public and private purchasers may seek greater transparency in origin of components as part of risk assessments, and contractual terms may increasingly include clauses addressing tariff pass-throughs or supply disruption contingencies. Collectively, these dynamics underscore the importance of proactive supply chain risk management and scenario planning to maintain continuity in clinical access.

Deep segmentation intelligence revealing how application, end user, technology, device type, channel, and delivery mode shape differentiated clinical and commercial strategies

Segmentation analysis reveals distinct clinical, operational, and commercial imperatives across application, end user, technology, delivery device type, distribution channel, and mode of delivery. Based on Application, market study spans Adult populations-where Hypoxemia in Cardiac Surgery and Pulmonary Hypertension represent divergent clinical pathways requiring different dosing strategies and monitoring intensity-as well as Neonatal populations where Hypoxemic Respiratory Failure and Persistent Pulmonary Hypertension of the Newborn demand highly sensitive control and rigorous safety features; Pediatric patients bridge these domains and often require devices adaptable to size and dosing complexity. Based on End User, the spectrum includes Ambulatory Care Centers and Clinics that prioritize throughput and ease of setup, Home Healthcare programs that emphasize portability and caregiver training, and Hospitals where integration with critical care systems and interoperability are paramount.

Based on Technology, options range from Cylinder Gas systems, which are familiar and widely deployed for their simplicity, to Electronic Generators that offer programmable dosing and reduced cylinder dependency; among Electronic Generators, distinctions between Fixed and Portable units drive placement decisions and influence procurement criteria. Based on Delivery Device Type, Integrated Systems that combine delivery and monitoring challenge traditional procurement processes, while Standalone devices can be attractive for modular deployments and retrofit scenarios. Based on Distribution Channel, Direct Sales arrangements support clinical training and contracting, Distributors can expand geographic reach and inventory support, and Online Channels provide a complementary route for ancillary products and consumables. Finally, based on Mode Of Delivery, Continuous therapies prioritize stability and long-term management capabilities, whereas Intermittent delivery requires robust titration features and rapid response monitoring. Together, these segmentation lenses inform tailored commercial strategies, clinical training requirements, and product roadmaps, underscoring that a one-size-fits-all approach is unlikely to meet the nuanced needs of diverse stakeholders.

Regional market dynamics and clinical adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence access, procurement, and commercialization

Regional dynamics materially influence clinical adoption patterns, reimbursement approaches, and the strategic priorities of manufacturers and distributors. In the Americas, strong academic medical centers and a concentration of cardiothoracic and neonatal specialty programs create focal points for early clinical adoption and real-world evidence generation, and procurement cycles often reflect integrated value assessments and negotiations with large health systems. As a result, there is heightened attention to device interoperability, service support models, and contractual terms that enable long-term clinical studies.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks, hospital procurement structures, and payer models vary widely across countries. In many European markets, centralized health technology assessment bodies and regional procurement consortia shape adoption decisions and require robust clinical and economic evidence. In parts of the Middle East and Africa, investment in tertiary care capacity is expanding, creating opportunities for suppliers that can provide comprehensive training and lifecycle support. Market entrants in this region commonly prioritize adaptable service models and locally compliant installation and maintenance capabilities.

Asia-Pacific exhibits rapid infrastructural growth in critical and neonatal care, coupled with an emphasis on domestic manufacturing in several countries. This combination yields a dual strategy for international suppliers: partnering with local manufacturers to navigate regulatory and procurement pathways, and offering differentiated products that address the demand for portable and easy-to-use devices in both urban tertiary centers and decentralized care settings. Across all regions, supply chain resilience, regulatory alignment, and evidence of clinical benefit remain core considerations in planning market access and commercial operations.

How leading manufacturers and service providers are differentiating through safety, evidence generation, and adaptable commercial models to secure clinical adoption

Leading companies active in the inhaled nitric oxide delivery space are investing across multiple fronts: engineering for safety and usability, building evidence packages that demonstrate clinical differentiation, and expanding service portfolios to support long-term device uptime. Technology leaders emphasize integration of monitoring, alarms, and interoperability with hospital information systems to reduce clinician burden and enable safer titration protocols. Competitors focused on gas-cylinder solutions maintain relevance by optimizing supply logistics and providing robust support networks for institutions where electronic generators have not yet achieved broad uptake.

Strategic behaviors include pursuing partnerships with clinical research networks to accelerate post-market surveillance and outcomes data, forming distribution alliances to broaden geographic reach, and pursuing modular product strategies that allow incremental upgrades without large capital replacement. Companies that excel in training and clinician engagement gain traction in neonatal and pediatric settings where operator familiarity and safety culture are critical. Meanwhile, firms that adopt flexible commercial models-leasing, managed services, and bundled consumable programs-strengthen relationships with health systems seeking predictable operating expenses. The competitive landscape is therefore characterized by a blend of technological differentiation, evidence generation, and service-oriented commercial models, each of which contributes to long-term adoption and customer retention.

Actionable strategic initiatives that industry leaders can implement to accelerate uptake, build resilience, and demonstrate clinical and economic value in complex healthcare systems

Industry leaders should prioritize a set of actionable initiatives to strengthen market position, enhance clinical impact, and reduce operational risk. First, invest in robust post-market evidence programs that measure not only physiological endpoints but also operational outcomes such as length of stay, readmission, and caregiver burden; these data will support reimbursement discussions and hospital procurement decisions. Second, develop flexible commercial models that align with customer preferences, including options for capital leasing, managed services, and outcomes-linked agreements that distribute risk and incentivize long-term partnerships. Third, enhance device interoperability and digital integration to reduce clinician workload and facilitate data capture for quality improvement initiatives.

In parallel, supply chain diversification is essential: map critical components, qualify alternative suppliers, and consider localized manufacturing or assembly to mitigate tariff exposure and logistical disruption. Strengthen training and credentialing programs targeted at neonatal and pediatric teams, as these areas are particularly sensitive to operator expertise and safety culture. Finally, collaborate with payers, hospital procurement groups, and clinical thought leaders to develop value narratives that articulate both clinical benefit and economic rationale, thereby smoothing pathways to adoption across varied care settings and geographies.

A rigorous mixed-methods research methodology blending primary clinical interviews, device technical analysis, and regulatory review to ensure balanced, actionable insights

This research employs a mixed-methods approach combining qualitative expert interviews, device specification analysis, regulatory literature review, and synthesis of peer-reviewed clinical evidence to produce an integrated view of the inhaled nitric oxide delivery landscape. Primary insights were derived from structured interviews with clinicians across neonatal, pediatric, and adult cardiopulmonary specialties, procurement leaders at acute and ambulatory care institutions, and senior executives at device manufacturers and distributors. These perspectives were triangulated with device technical documentation and regulatory filings to assess safety features, interoperability capabilities, and device classifications across jurisdictions.

Secondary analysis incorporated systematic review of clinical studies, guidelines, and consensus statements to contextualize application-specific requirements and safety considerations. Supply chain and commercial dynamics were evaluated through examination of public procurement frameworks, industry reports, and case studies of recent product launches and market entry strategies. Throughout the methodology, emphasis was placed on corroborating claims through multiple independent sources and prioritizing primary clinical input where discrepancies arose, ensuring that conclusions reflect a balanced synthesis of clinical relevance, technological capability, and operational feasibility.

Concluding synthesis that ties together clinical imperatives, technological trends, and organizational strategies to guide adoption and long-term planning

Inhaled nitric oxide delivery systems are positioned at an inflection point where clinical need, technology maturation, and shifting care delivery models intersect. The device landscape will continue to be shaped by demands for improved safety, greater portability, and demonstrable outcomes that justify broader use across ambulatory and home settings as well as traditional hospital environments. Manufacturers and suppliers that align product development with the operational realities of neonatal and adult critical care, while simultaneously investing in evidence generation and supply chain resilience, will be best placed to capture sustained clinical adoption.

For clinical leaders and procurement professionals, the imperative is to evaluate devices not only on immediate performance metrics but also on integration potential, training requirements, and lifecycle service commitments. Forward-looking strategies that combine technological differentiation, flexible commercial models, and proactive risk mitigation will enable organizations to deliver better patient outcomes at manageable total cost of care. Ultimately, the convergence of these elements will determine which technologies become standard of care across diverse clinical settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Inhaled Nitric Oxide Delivery Systems Market, by Technology

  • 8.1. Cylinder Gas
  • 8.2. Electronic Generator
    • 8.2.1. Fixed
    • 8.2.2. Portable

9. Inhaled Nitric Oxide Delivery Systems Market, by Delivery Device Type

  • 9.1. Integrated Systems
  • 9.2. Standalone

10. Inhaled Nitric Oxide Delivery Systems Market, by Mode Of Delivery

  • 10.1. Continuous
  • 10.2. Intermittent

11. Inhaled Nitric Oxide Delivery Systems Market, by Application

  • 11.1. Adult
    • 11.1.1. Hypoxemia In Cardiac Surgery
    • 11.1.2. Pulmonary Hypertension
  • 11.2. Neonatal
    • 11.2.1. Hypoxemic Respiratory Failure
    • 11.2.2. Persistent Pulmonary Hypertension Of The Newborn
  • 11.3. Pediatric

12. Inhaled Nitric Oxide Delivery Systems Market, by End User

  • 12.1. Ambulatory Care Centers
  • 12.2. Clinics
  • 12.3. Home Healthcare
  • 12.4. Hospitals

13. Inhaled Nitric Oxide Delivery Systems Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Channels

14. Inhaled Nitric Oxide Delivery Systems Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Inhaled Nitric Oxide Delivery Systems Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Inhaled Nitric Oxide Delivery Systems Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Inhaled Nitric Oxide Delivery Systems Market

18. China Inhaled Nitric Oxide Delivery Systems Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Air Liquide S.A.
  • 19.6. Air Products and Chemicals, Inc.
  • 19.7. Air Water Inc.
  • 19.8. Bellerophon Therapeutics, Inc.
  • 19.9. Beyond Air, Inc.
  • 19.10. Chart Industries, Inc.
  • 19.11. Dragerwerk AG & Co. KGaA
  • 19.12. EKU Elektronik GmbH
  • 19.13. GE HealthCare Technologies Inc.
  • 19.14. Getinge AB
  • 19.15. INO Therapeutics LLC
  • 19.16. International Biomedical Ltd.
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Linde plc
  • 19.19. Mallinckrodt Pharmaceuticals plc
  • 19.20. Medtronic plc
  • 19.21. Merck KGaA
  • 19.22. Messer Group GmbH
  • 19.23. NIOX Group plc
  • 19.24. Novoteris, LLC
  • 19.25. NU-MED Plus, Inc.
  • 19.26. SLE Ltd.
  • 19.27. Taiyo Nippon Sanso Corporation
  • 19.28. Teleflex Incorporated
  • 19.29. VERO Biotech LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CYLINDER GAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY INTERMITTENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIA IN CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PULMONARY HYPERTENSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HYPOXEMIC RESPIRATORY FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 172. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 176. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 177. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. GCC INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 202. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 204. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 206. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 207. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. G7 INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 212. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 216. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 217. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ELECTRONIC GENERATOR, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY NEONATAL, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA INHALED NITRIC OXIDE DELIVERY SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)